United States· US:0121-4027_0a44f05f-6cf7-4264-a228-1372bf0e9154
Lithium
A lithium product containing lithium citrate, registered in United States by PAI Holdings, LLC dba PAI Pharma. The same ATC class is registered in 15 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Lithium is registered in 15 of 19 countries.
Countries holding a registration under ATC N05AN01 (lithium), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Lithium · ATC N05AN01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LITHIUM CITRATE
- Manufacturer
- PAI Holdings, LLC dba PAI Pharma
- Country
- United States (US)
- ATC code
- N05AN01
- ATC class
- Lithium
- Defined daily dose
- 24 mmol, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc110121-4027-94
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
428 interactions on record for lithium.
Graded by severity as the source publishes them — 73 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lithium · interactions on record
428 records
- 73 severe
- 250 moderate
- 15 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
90 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lithium in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCamcolit 250 tabletsEssential Pharma Ltd
- NorwayApo-Lithium carbonateApotex
- CanadaAPO-LITHIUM CARBONATEAPOTEX INC
- NetherlandsCamcolit-250, tabletten 250 mgEssential Pharma Limited
- BelgiumCamcolit 250 250 mgEssential Pharma (M)
- SwitzerlandLiDCO Lithiumchlorid 0.15 mmol/ml, InjektionslösungRegulix GmbH
- Japan炭酸リチウムトクホン
- FranceGRANIONS DE LITHIUM 1 mg/ 2 ml, solution buvable en ampouleGRANIONS
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Lithiumchlorid Lidco, Neurolepsin
- Belgium · Camcolit
- Bulgaria · Lithibalance
- Cyprus · Plenur
- Czechia · Lithium Carbonicum Slovakofarma, Lithium Chlorid Lco
- Germany · Hypnorex Retard, Quilonum Retard
- Denmark · Carblit, Litarex
- Spain · Cloruro De Litio Lidco Netherlands, Plenur
- Finland · Lito
- France · Lithioderm, Lithium Granions
- United Kingdom (Northern Ireland) · Camcolit, Li-Liquid
- Greece · Milithin
- Croatia · Litijev Karbonat Jgl, Litijev Klorid Lidco
- Hungary · Liticarb
- Ireland · Camcolit, Lithium Chloride Lidco Netherlands
- Iceland · Litarex
- Italy · Carbolithium, Litio Carbonato L.F.M.
- Luxembourg · Camcolit, Oligosol
- Netherlands · Camcolit, Carblit
- Norway · Carblit, Lithium Chloride Lidco
- Poland · Lithium Carbonicum Gsk
- Portugal · Plenur, Priadel
- Sweden · Carblit, Lithionit
- Slovenia · Litijev Karbonat Lekarna Ljubljana
- Slovakia · Lithium Carbonicum Slovakofarma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c39dcc52-ed2e-4a1a-bcee-e7f2ee297d62 GET /v1/drugs/c39dcc52-ed2e-4a1a-bcee-e7f2ee297d62?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "8",
"substance": "LITHIUM CITRATE",
"productndc": "0121-4027",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "meq/5mL",
"application_number": "ANDA070755",
"marketing_category": "ANDA"
}See everything about lithium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.